The study found no mean difference in all-cause healthcare costs for patients with newly diagnosed nonvalvular atrial fibrillation initiating treatment with dabigatran versus warfarin.
John C. White, DPM, MS
Advertisement
Articles by John C. White, DPM, MS
Advertisement
Latest Updated Articles
- Predictors of Healthcare Costs After Initiating Dabigatran Versus Warfarin
Published: February 2nd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Review of Antibody-Drug Conjugates for the Treatment of Urothelial Carcinoma: The Rise of Enfortumab Vedotin
2
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
3
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
4
FDA Approves First Drug for Pediatrics With Irritable Bowel Syndrome With Constipation
5
